Republicans, Democrats Gang Up on Allergan at U.S. House Hearing

Drug Industry Daily
A A
Allergan drew bipartisan fire from U.S. House members considering issues raised by the company’s innovative scheme to shield its patents on the blockbuster dry-eye drug Restasis from challenges before the Patent Trial and Appeal Board.

To View This Article:

Login

Subscribe To Drug Industry Daily